Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in FDA Week, in “Cures Exempts Some Medical Software; More Clarity Needed, Attorneys Say,” by David Lim. (Read the full version – subscription required.)

Following is an excerpt:

Thompson agreed, saying the uncertainty with the Trump administration might delay a CDS guidance even further, despite a need for additional clarity over what is considered low-risk or high-risk software.

"What FDA considers high versus low risk is still unclear -- so we're still very desperately waiting for FDA to publish the guidance document and I have no idea even now if that is going to happen," Thompson said to IHP. He added that he would have liked to see a directive in Cures for FDA to issue the CDS guidance, but said that would have been controversial because the guidance might have been viewed as a new regulation.

"CDS guidance may be viewed as increasing regulation, I don't view it that way, but it's caught up in politics now. Honestly I'm very frustrated, there seems to be always some reason not to publish it. Industry is not a mind reader; we cannot read FDA's mind about what it considers software that needs to be regulated. FDA is sort of absent from all of this, if they are not going to regulate it, that's fine too, but it's the ambiguity that is so frustrating. There are a lot of ethical companies that want to get into software but don't know what the regulatory pathway looks like."

FDA should issue narrowly crafted advisory opinions to clarify regulatory decisions for new technologies in order to more timely get information to industry, Thompson previously said in an Aug. 16 citizen petition to FDA on behalf of the CDSC.

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.